Rare clot risk linked to Johnson & Johnson COVID-19 vaccine should be explained to younger women, CDC says
Fox News
Patients should be informed of a rare but serious clotting risk following vaccination with Johnson & Johnson’s single-dose COVID-19 jab, especially women under the age of 50, federal health authorities warn.
The CDC is now investigating two new clotting cases that occurred alongside low platelets, bringing the total number of instances to 17. A CDC spokesperson told Fox News that one case of thrombosis with thrombocytopenia syndrome (TTS) under investigation occurred in a male vaccine recipient, and the other in a female, both under age 60. Thus, all but one reported clotting cases have occurred among women aged 18-59. The greatest risks were reported among women aged 30 to 39 at a reporting rate of 11.8 TTS cases per million doses administered.More Related News